J. Lujan, G. Valero, Q. Hernandez, A. Sanchez, M.D. Frutos and P. Parrilla. British Journal of Surgery, September 2009.

Slides:



Advertisements
Similar presentations
Neoadjuvant therapy for Rectal cancer
Advertisements

IN THE NAME OF GOD. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy The American Journal.
Oncologic Results of Laparoscopic Versus Conventional Open Surgery for Stage II or III Left-Sided Colon Cancers A Randomized Controlled Trial A randomized.
NPCA data collection on men undergoing radical surgery for prostate cancer Paul Cathcart, NPCA Urology Project Coordinator.
North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014.
Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
A COMPARISON of LAPAROSCOPICALLY ASSISTED and OPEN COLECTOMY for COLON CANCER The Clinical Outcomes of Surgical Therapy Study Group (Cost Study) NEJM,
JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.
CA Esophagus – Role of Chemoirradiation WH Chan Pamela Youde Nethersole Eastern Hospital.
ANDREW NG PRINCE OF WALES HOSPITAL Role of primary chemoradiation in esophageal carcinoma.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP.
Colorectal cancer in Norway Maria Mai Ingvild Hvalby.
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
Capecitabine versus 5-fluorouracil-based (neo-)adjuvant chemo-radiotherapy for locally advanced rectal cancer: Long term results.
Birga Terlunen-Traboldt ENT-Journal Club Need for Neck dissection after Radiochemotherapy? A study of the French GETTEC Group Vedrine P;Thariat J;Hitier.
Failure of Treatment in Cervical Cancer Patients *Dr. Zohreh Yousefi fellow ship of gynecology oncology of Mashhad university Fatemeh Homaee, Marzieh.
COLON CANCER A MAJOR ISSUE IN ALASKA. A common malignancy 200,000 cases in the U. S. in ,000 cases in the U. S. in 2008 Greater than 50 new cases.
Postoperative Radiotherapy for Patients with Stage II or III Nonsmall Cell Lung Cancer treated with Sublobar Resections: A SEER Registry Analysis Scott.
Laparoscopic Pancreatectomy Attila Nakeeb, M.D., F.A.C.S. Department of Surgery Indiana University School of Medicine 7th Annual Symposium on Gastrointestinal.
The Impact of Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Patients with Carcinoma of the Rectum: NSABP R-04 1 Capecitabine.
Gastric Cancer Gidon Almogy MD Department of General Surgery Hadassah University Hospital.
Minimally Invasive Esophagectomy Dmitry Oleynikov M.D. Associate Professor of Surgery Joseph and Richard Still Faculty Fellow in Medicine Director of Minimally.
Protocols for Advanced Prostate Cancer and/or Local Failure After Radical Prostatectomy Isaac Powell, MD.
Exit Examinations European view M62 Coloproctolgy course, Huddersfield Lars Påhlman Dept. Surgery, Colorectal unit University Hospital, Uppsala, Sweden.
Accuracy of EUS in diagnosis of rectal cancer KKUH experience
AUDIT OF DOWN-STAGING CHEMORADIATION FOR LOCALLY ADVANCED RECTAL CANCER DR J J NICOLL NORTH CUMBRIA UNIVERSITY HOSPITALS SEPTEMBER 2012.
A comparison of open vs laparoscopic emergency colonic surgery; short term results from a district general hospital. D Vijayanand, A Haq, D Roberts, &
Evidence for a Survival Benefit Conferred by Adjuvant Radiotherapy in a Cohort of 608 Women with Early-stage Endometrial Cancer O. Kenneth Macdonald 1,
High Dose Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes Tania Kaprealian 1, Vivian Weinberg 3, Joycelyn.
Extranodal Extension on Sentinel Lymph Node Dissection: Why Should We Treat It Differently? Audrey Choi MD, Matthew Surrusco MD, Samuel Rodriguez MD, Khaled.
Preliminary Results of the MRC CR07 / NCIC CO16 Randomized Trial Short course pre-op vs selective post-op chemo-RT for rectal cancer Local Recurrence after.
Journal Club Dr. Eyad Al-Saeed Radiation Oncology 12 January, 2008.
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
Important questions As good or better ? Cost effective ? Overall, safer? Is it safe as a cancer operation? Can all surgeons do it? Compare to open surgery.
Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Outcome of Salvage Total Laryngectomy Following Organ.
Colon Cancer. What is Colon Cancer?  Cancer that begins in the colon or rectum  The colon and rectum are both parts of the large intestine  The third.
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer NEJM July vol 359 R2 임규성.
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
Presented By Shin Fujita at 2016 ASCO Annual Meeting
ELIGIBILITY CRITERIA- Summarised
Laparoscopic surgery for rectal cancer What is the evidence?
Karcinom rektuma- management
Esophagectomy for cancer:
A Systematic Review and Meta-analysis
Department of General Surgery, Upper Gastrointestinal Unit,
นายแพทย์ธราธร ตุงคะสมิต นายแพทย์ชำนาญการพิเศษ โรงพยาบาลมะเร็งอุดรธานี
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Relationship between the site of esophageal carcinoma and survival of patients with locally advanced disease Authors: Andrea Masarykova, Ingrid Zavacka,
OPTIMIZING TREATMENT FOR ADVANCED OVARIAN CANCER:
Laparoscopic vs Open Colonic Surgery: Long Term Survival
Dr Jessica Jenkins Consultant Oncologist
Impact of lymph node ratio and number on survival in patients with rectal adenocarcinoma after preoperative chemo radiation  Abu Bakar Hafeez Bhatti,
PRESENTATOR: MD VƯƠNG NHẤT PHƯƠNG. HO CHI MINH CITY ONCOLOGY HOSPITAL
Effect of Neoadjuvant Concurrent Chemoradiotherapy on Locally Advanced Middle and Low Rectal Cancer— A Propensity Score Matching Study 官泰全,林春吉,楊純豪,姜正愷,林宏鑫,藍苑慈,
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Neoadjuvant Adjuvant Curative Palliative
Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia  Caroline Mariano, MD, Diana N. Ionescu, MD, Winson.
Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed  Emanuela Taioli, MD, PhD, Raja Flores, MD 
Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base  Susan E. Combs, MA, Jacquelyn.
Outcome of Multimodality Treatment for 188 Cases of Type B3 Thymoma
Assessment of Breast and Colorectal Cancer Surgery in Manitoba
Sebastien Gilbert, MD, Andre B. Martel, BSc, Andrew J
Neoadjuvant Chemoradiation Therapy Is Beneficial for Clinical Stage T2 N0 Esophageal Cancer Patients Due to Inaccurate Preoperative Staging  Jennifer.
Presentation transcript:

J. Lujan, G. Valero, Q. Hernandez, A. Sanchez, M.D. Frutos and P. Parrilla. British Journal of Surgery, September 2009

Background The laparoscopic treatment of rectal cancer is controversial. This study compared surgical out comes after laparoscopic and open approaches for mid and low rectal cancers. Methods Some 204 patients with mid and low rectal adenocarcinomas were allocated randomly to open(103) or laparoscopic (101) surgery. The surgical team was the same for both procedures. Most patients had stage II or III disease, and received neoadjuvant therapy with oral capecitabine and Gy external beam radiotherapy. Patients with locally advanced disease (T4) or familial adenomatous polyposis and those who underwent emergency surgery were excluded.

Results Sphincter-preserving surgery was performed in 81(78.6) and 77(76.2) per cent of patients in the open and laparoscopic groups respectively. A defunctioning ileostomy was created in 60.8 per cent of patients who had sphincter- preserving surgery with no difference between groups. Blood loss was significantly greater for open surgery (P<0.001) and operating time was significant greater for laparoscopic surgery (P=0.020), and return to diet and hospital stay were longer for open surgery. Complication rates, and involvement of circumferential and radial margins were similar for both procedures, but the number of lymph nodes was greater in the laparoscopic group (mean 13.6 versus 11.57; P=0.026). There were no differences in local recurrence, disease- free or overall survival.

Conclusions Laparoscopic surgery for rectal cancer has similar complications rate to open surgery, with less blood loss, rapid intestinal recovery, shorter hospital stay, and no compromise of oncological outcomes.